DrugsControl Media Services
DrugsControl.org
Home  |  News  |  Sitemap  |  Contact Us  |   Login

Register
notification
Advertise with us

News Detail

PLI Scheme fuels Domestic Manufacturing of Penicillin G, Clavulanic Acid (03-04-2024)

New Delhi, 3 Apr 2024 (KNN) India's efforts to reduce its dependence on China for crucial drugs have received a significant boost, with two domestic drug makers poised to commence production of the key antibiotic raw materials, penicillin G and clavulanic acid, this year......
View Details

Source : KNN
New Delhi Apr 2 (KNN) India's efforts to reduce its dependence on China for crucial drugs have received a significant boost with two domestic drug makers poised to commence production of the key antibiotic raw materials penicillin G and clavulanic acid this year. This development is made possible by the government's ambitious Production-Linked Incentive (PLI) scheme designed to bolster domestic manufacturing of essential pharmaceutical ingredients reported ET. According to industry executives the stage is set for Hyderabad-based Aurobindo Pharma and Mumbai-headquartered Kinvan to begin production of the key starting materials (KSMs) penicillin G and clavulanic acid respectively. The companies are expected to roll out their first batches in the coming months marking a significant milestone in India's pursuit of self-reliance in the pharmaceutical sector. Penicillin G a crucial input for several antibiotics and clavulanic acid used in manufacturing the widely popular anti

Related News